Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α

Circulation Research

Volumn 81, Issue 4, 1997, Pages 627-635

  Kuhota, Toru ^a   McTiernan, Charles F ^a   Frye, Carole S ^a   Slawson, Susan E ^b   Lemster, Bonnie H ^a   Koretsky, Alan P ^b   Demetris, A Jake ^a   Feldman, Arthur M ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Heart failure; Transgenlc mouse; Tumor necrosis factor

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ISOPRENALINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HEART DILATATION; HEART EJECTION FRACTION; LUNG WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030763808     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.res.81.4.627     Document Type: Article

References (48)

1. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumor necrosis factor, Lancet. 1989; 1 :1122- 1126.
2. Vilcek J, Lee TH. Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J Biol Chem. 1991;266:7313-7316.
3. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;223:236-241.
4. McMurray J, Abdullah I, Dargic HJ, Shapiro D. Increased concentrations of tumor necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J. 1991;66:356-358.
5. Dutka DP, Elborn JS, Delamore F, Shale DJ, Morris G. Tumor necrosis factor α in severe congestive cardiac failure, Br Heart J. 1993;70:141-143.
6. Matsumori A, Yamada T, Suzuki H, Matoha Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561-566.
7. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92:1479-1486.
8. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coil Cordiol. 1996;27:1201-1206.
9. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive failure due to coronary artery disease or hypertension. J Am Coll Cardiol, 1996;28:964-971.
10. MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol. 1997;79:1128-1131.
11. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest. 1992;90:693-698.
12. Kapadia S, Lee JR, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. J Clin lnvest. 1995;96:1042-1052.
13. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bios RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
14. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopalhy. Lancet. 1996;347:1151-1155.
15. Doyama K, Fujiwara H, Fukumoto M, Tanaka M, Fujiwara Y, Oda T, Inada T, Ohtani S, Hasegawa K, Fujiwara T, Sasayama S. Tumor necrosis factor is expressed in cardiac tissues of patients with heart failure. Int J Cardiol, 1996;54:217-225.
16. Satoh M, Nakamura M, Tamura G, Makita S, Segawa I, Tashiro A. Satodate R, Hiramori K. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol. 1997;29:716-724.
17. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation. 1995;92:1487-1493.
18. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
19. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest. 1993;92:2303-2012.
20. 2+], and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol. 1996;271(Heart Circ Physiol 40):H1449-H1455.
21. Stein B, Frank P, Schmitzz W, Scholz H, Thoenes M. Endotoxin and cylokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol. 1996;28:1631-1639.
22. β proteins and adenylyl cyclase responsiveness in rat cardiomyocytes. Eur J Pharmacol. 1991;206:53-60.
23. Feldman AM, Cates AE, Veazéy WB, Hershberger RE, Bristow MR, Baughman KL, Baugartner WA, Van Dop C. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988;82:189-197.
24. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracelluar calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987;61:70-76.
25. Kubota T, McTieman CF, Frye CS, Demetris AJ, Feldman AM. Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice.J Cardiac Fail. 1997;3:117-124.
26. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA. 1986;83:1670-1674.
27. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986;46:659-667.
28. Gulick J, Subramaniam A, Neumann J, Robbins J. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem. 1991;266:9180-9185.
29. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J. Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 1991;266:24613-24620.
30. Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone, secreted by endotoxin-induced RAW 264.7 cells. J Exp Med. 1985;161:984-995.
31. Fransen L, Müller R, Marmenout A, Tavernier J, Van der Heyden J, Kawashima E. Chollet A, Tizard R, Van Heuverswyn H, Van Vliet A, Ruysschaert M-R. Fiers W. Molecular cloning of mouse tumor necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res. 1985;13:4417-4429.
32. Semon D, Kawashima E, Jongeneel CV, Shakhov AN, Nedospasov SA. Nucleotide sequence of the murine TNF locus, including the TNF-α (tumor necrosis factor) and TNF-β (lymphotoxin) genes. Nucleic Acid Res. 1987;15:9083-9084.
33. Gross-Bellard M, Oudet P, Chambon P. Isolation of highmolecular-weight DNA from mammalian cells. Eur J Biochem. 1973;36:32-38.
34. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
35. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phcnol-chloroform extraction. Anal Biochem. 1987;162:156-159.
36. Seidman CE, Duby AD, Choi E, Graham RM, Haber E, Homey C, Smith JA, Seidman JG. The structure of rat preproatrial natriuretic factor as defined by a complementary DNA done. Science. 1984;225:324-326.
37. Mendez RE, Pfeffer JM, Ortola FV, Bloch KD, Anderson S, Seidman JG, Brenner BM. Atrial natriuretic peptide transcription, storage, and release in rats with myocardial infarction. Am J Physiol. 1987;253(Heart Cric Physiol. 22):H1449-H1455.
38. Pizarro TT, Malinowska K, Kovacs EJ, Clancy J, Robinson JA, Piccinini LA. Induction of TNF-alpha and TNF-beta gene expression in rat cardiac transplants during allograft rejection. Transplantation. 1993;56:399-404.
39. Slawson SE, Roman BB, Koretsky AP. Cardiac MRI of the normal and hypertrophied mouse heart. Proc Intl Soc Magn Reson Med. 1997;1:890. Abstract.
40. Ko Y, Tang TK, Chen J, Hshieh Y, Wu C, Lien W. Idiopathic hypertrophic cardiomyopathy in identical twins: morphological heterogeneity of the left ventricle. Chest. 1992;102:783-785.
41. Hecht GM, Klues HG, Roberts WC, Maron BJ. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993;22:489-497.
42. Katz AM. The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart, Ann Intern Med. 1994;121:363-371.
43. Manning WJ, Wei JY, Katz SE, Litwin SE, Douglas PS. In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol. 1994;266(Heart Circ Physiol. 35):H1672-H1675.
44. Gardin JM, Siri FM, Kitsis RN, Edwards JG, Leinwand LA. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res. 1995;76:907-914.
45. Hoit BD, Khoury SF, Kranias EG, Ball N, Walsh RA. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res. 1995;77:632-637.
46. Tanaka N, Dalton N, Mao L. Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross JJ. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 1996;94:1109-1117.
47. 1 adrenergic receptor. J Invest Med. 1997;45:210A. Abstract.
48. sα overexpression. Circ Res. 1996;78:517-524.